![Nitrogen metabolism / Ikaria / Nitric oxide / NOx / Methemoglobinemia / Hepatorenal syndrome / Chemistry / Oxides / Health Nitrogen metabolism / Ikaria / Nitric oxide / NOx / Methemoglobinemia / Hepatorenal syndrome / Chemistry / Oxides / Health](https://www.pdfsearch.io/img/a0a66f09525bc3bf2fe612650ffda14b.jpg)
| Document Date: 2011-06-28 11:52:44 Open Document File Size: 111,11 KBShare Result on Facebook
City Madison / Seattle / Clinton / Port Allen / / Company IKARIA NAMED PRIVATE COMPANY / Ikaria Holdings Inc. / / Continent Europe / / Country Japan / Canada / Australia / / Event Employment Change / M&A / FDA Phase / / IndustryTerm manufacturing facility / technology community / pharmaceuticals / treatment of hepatorenal syndrome / technology / treatment of hypoxic respiratory failure / gas mixtures / / MedicalCondition airway inflammation / hypoxic respiratory failure / Methemoglobinemia / / Organization FDA / New Jersey Technology Council / / Person Daniel Tasse / / Position President and CEO / Private / / Product INOmax / INOmax® (nitric oxide) / / ProvinceOrState New Jersey / Wisconsin / Louisiana / Washington / / Region Latin America / / URL www.ikaria.com / www.inomax.com / /
SocialTag |